Literature DB >> 10325315

Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California.

M K York1, L Gibbs, F Perdreau-Remington, G F Brooks.   

Abstract

During 1994 and 1995, 157 isolates of Streptococcus pyogenes from patients with invasive disease were consecutively collected in the San Francisco Bay area to determine the frequency of antimicrobial resistance. Susceptibility testing was performed according to the guidelines of the National Committee for Clinical Laboratory Standards by the disk method and by broth microdilution. For comparison of susceptibility patterns, an additional 149 strains were randomly collected from patients with pharyngitis. For San Francisco County, 32% of the isolates from invasive-disease-related specimens but only 9% of the isolates from throat cultures from the same period were resistant to erythromycin (P = 0.0007). Alameda County and Contra Costa County had rates of resistance of </=10% from isolates from all cultures. When the data were analyzed by hospital, the San Francisco County Hospital had a statistically higher rate of erythromycin resistance (39%) among the strains from serious infections compared to those from other counties (P = <0. 0003). For tetracycline, high rates of resistance were observed in San Francisco County for both isolates from patients with invasive disease (34%) and pharyngitis (21%) in the same period. Using pulsed-field gel electrophoresis, two clones, one at the San Francisco County Hospital and a second in the entire area, were identified. The latter clone exhibited resistance to bacitracin. Of 146 strains that were tested by microdilution, all were susceptible to penicillin. Clindamycin resistance was not seen among the erythromycin-susceptible strains, but two of the 39 erythromycin-resistant strains were also resistant to clindamycin. An additional 34 strains showed resistance to clindamycin when exposed to an erythromycin disk in the double-disk diffusion test, suggesting that the mechanism of erythromycin resistance is due to an erm gene. This study demonstrates a high rate of resistance to macrolides and tetracycline among S. pyogenes isolates in San Francisco County and shows that macrolide resistance is more common in strains from patients with invasive disease than in strains from those with pharyngitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10325315      PMCID: PMC84935     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  High-resolution genotyping elucidates the epidemiology of group A streptococcus outbreaks.

Authors:  J Stanley; M Desai; J Xerry; A Tanna; A Efstratiou; R George
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

2.  Pulsed-field gel electrophoresis is more discriminating than multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for typing pyogenic streptococci.

Authors:  F Bert; C Branger; N Lambert-Zechovsky
Journal:  Curr Microbiol       Date:  1997-04       Impact factor: 2.188

3.  The regression line for erythromycin is not valid for beta-hemolytic streptococci group A.

Authors:  J E Brorson; P Larsson
Journal:  Scand J Infect Dis       Date:  1987

Review 4.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

5.  Novel mechanism of macrolide resistance in Streptococcus pneumoniae.

Authors:  V D Shortridge; R K Flamm; N Ramer; J Beyer; S K Tanaka
Journal:  Diagn Microbiol Infect Dis       Date:  1996-10       Impact factor: 2.803

Review 6.  Recent evaluation of antimicrobial resistance in beta-hemolytic streptococci.

Authors:  E L Kaplan
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

7.  Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes.

Authors:  J Clancy; J Petitpas; F Dib-Hajj; W Yuan; M Cronan; A V Kamath; J Bergeron; J A Retsema
Journal:  Mol Microbiol       Date:  1996-12       Impact factor: 3.501

8.  Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance.

Authors:  G Cornaglia; M Ligozzi; A Mazzariol; M Valentini; G Orefici; R Fontana
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

Review 9.  Antibiotic resistance in group A streptococci.

Authors:  M A Gerber
Journal:  Pediatr Clin North Am       Date:  1995-06       Impact factor: 3.278

10.  Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan.

Authors:  P R Hsueh; H M Chen; A H Huang; J J Wu
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

View more
  28 in total

1.  Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries.

Authors:  Kensuke Nagai; Peter C Appelbaum; Todd A Davies; Linda M Kelly; Dianne B Hoellman; Arjana Tambic Andrasevic; Liga Drukalska; Waleria Hryniewicz; Michael R Jacobs; Jana Kolman; Jolanta Miciuleviciene; Marina Pana; Lena Setchanova; Marianne Konkoly Thege; Helena Hupkova; Jan Trupl; Pavla Urbaskova
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Dissemination of emm28 erythromycin-, clindamycin- and bacitracin-resistant Streptococcus pyogenes in Spain.

Authors:  E Perez-Trallero; C Garcia; B Orden; J M Marimon; M Montes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-08       Impact factor: 3.267

3.  Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics.

Authors:  Liliana Mihaila-Amrouche; Anne Bouvet; Julien Loubinoux
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

4.  Antistreptococcal activity of AR-709 compared to that of other agents.

Authors:  Kathy Smith; Lois M Ednie; Peter C Appelbaum; Stephen Hawser; Sergio Lociuro
Journal:  Antimicrob Agents Chemother       Date:  2008-03-24       Impact factor: 5.191

5.  Utilisation of macrolides and the development of Streptococcus pyogenes resistance to erythromycin.

Authors:  Karel Urbánek; Milan Kolár; Luboslava Cekanová
Journal:  Pharm World Sci       Date:  2005-04

6.  Detection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin-clindamycin combinations.

Authors:  Jason E Bowling; Aaron E Owens; M Leticia McElmeel; Letitia C Fulcher; Monica L Herrera; Brian L Wickes; James H Jorgensen
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

7.  Failure of clindamycin to eradicate infection with beta-hemolytic streptococci inducibly resistant to clindamycin in an animal model and in human infections.

Authors:  James S Lewis; Alex J Lepak; George R Thompson; William A Craig; David R Andes; Kathryn E Sabol-Dzintars; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

8.  Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes.

Authors:  K Nagai; T A Davies; L M Ednie; A Bryskier; E Palavecino; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

9.  Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.

Authors:  Meredith E Hasenbein; John E Warner; Kathleen G Lambert; Sarah E Cole; Andrew B Onderdonk; Alexander J McAdam
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Prevalence of the erm(T) gene in clinical isolates of erythromycin-resistant group D Streptococcus and Enterococcus.

Authors:  Linda P DiPersio; Joseph R DiPersio; Kevin C Frey; Jacqueline A Beach
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.